Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagstrom-Toft, E.
Right arrow Articles by Arner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagstrom-Toft, E.
Right arrow Articles by Arner, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 10 1170-1175, Copyright © 1995 by American Diabetes Association


ARTICLES

Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo

E Hagstrom-Toft, J Bolinder, S Eriksson and P Arner
Department of Medicine, Huddinge Hospital, Karolinska Institute, Sweden.

The effect of three types of phosphodiesterase (PDE) inhibitors on in vivo antilipolysis was investigated in healthy subjects using a 2-h euglycemic, hyperinsulinemic (40 mU.m-2.min) clamp together with microdialysis of abdominal subcutaneous adipose tissue. During hyperinsulinemia (approximately 330 pmol/l), the circulating glycerol concentration was reduced to approximately 50% of the basal level of 53.2 +/- 3.6 mumol/l, indicating an antilipolytic effect. The decrease in adipose tissue dialysate glycerol, which mirrors the change in interstitial glycerol concentration, was about 40% during hyperinsulinemia when Ringer's solution alone was perfused. Local perfusion with a selective PDE IV inhibitor, rolipram (10(-4) mol/l), did not influence the insulin-induced decrease in dialysate glycerol (F = 0.8 vs. perfusion with Ringer's solution by two-factor analysis of variance [ANOVA]), although rolipram increased the dialysate glycerol level by 144 +/- 7% of the baseline value. However, local perfusion with a selective PDE III inhibitor, amrinone (10(-3) mol/l), or a nonselective PDE inhibitor, theophylline (10(-2) mol/l), abolished the ability of insulin to lower dialysate glycerol (F = 16.5, P < 0.01 and F = 8.5, P < 0.01, respectively, as compared with perfusion with Ringer's solution). The findings could not be explained by changes in the local blood flow (as measured by a microdialysis--ethanol escape technique), which was not affected by hyperinsulinemia in the presence or the absence of PDE inhibitors in the dialysis solvent. We conclude that PDEs play an important role in mediating the antilipolytic effect of insulin in vivo and that PDE III is the dominant isoenzyme modulating this effect.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
P. B. Snyder, J. M. Esselstyn, K. Loughney, S. L. Wolda, and V. A. Florio
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
J. Lipid Res., March 1, 2005; 46(3): 494 - 503.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Moberg, S. Sjoberg, E. Hagstrom-Toft, and J. Bolinder
No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E295 - E301.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman
C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes
Diabetes, March 1, 2002; 51(3): 631 - 637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Stallknecht, J. J. Larsen, K. J. Mikines, L. Simonsen, J. Bulow, and H. Galbo
Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E376 - E385.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-T. van der Merwe, P.-A. Jansson, N. J. Crowther, I. H. Boyd, I. P. Gray, B. I. Joffe, and P. N. Lönnroth
Lactate and Glycerol Release from Subcutaneous Adipose Tissue in Black and White Lean Men
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2888 - 2895.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. Van Harmelen, S. Reynisdottir, K. Cianflone, E. Degerman, J. Hoffstedt, K. Nilsell, A. Sniderman, and P. Arner
Mechanisms Involved in the Regulation of Free Fatty Acid Release from Isolated Human Fat Cells by Acylation-stimulating Protein and Insulin
J. Biol. Chem., June 25, 1999; 274(26): 18243 - 18251.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ellmerer, L. Schaupp, G. Sendlhofer, A. Wutte, G. A. Brunner, Z. Trajanoski, F. Skrabal, P. Wach, and T. R. Pieber
Lactate Metabolism of Subcutaneous Adipose Tissue Studied by Open Flow Microperfusion
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4394 - 4401.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. T. van der Merwe, N. J. Crowther, G. P. Schlaphoff, I. H. Boyd, I. P. Gray, B. I. Joffe, and P. N. Lönnroth
Lactate and Glycerol Release from the Subcutaneous Adipose Tissue of Obese Urban Women from South Africa; Important Metabolic Implications
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4084 - 4091.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.